{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:56:33Z","timestamp":1789412193871,"version":"build-2803163510"},"reference-count":72,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["W1224-B09"],"award-info":[{"award-number":["W1224-B09"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001821","name":"Vienna Science and Technology Fund","doi-asserted-by":"publisher","award":["COV20-015"],"award-info":[{"award-number":["COV20-015"]}],"id":[{"id":"10.13039\/501100001821","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovative Medicines Initiative 2 Joint Undertaking","award":["101005026"],"award-info":[{"award-number":["101005026"]}]},{"name":"DOC fellowship of the Academy of Sciences","award":["24987"],"award-info":[{"award-number":["24987"]}]},{"name":"T. von Zastrow foundation"},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["Z271-B19"],"award-info":[{"award-number":["Z271-B19"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","award":["F18-0133"],"award-info":[{"award-number":["F18-0133"]}],"id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["F20-02343"],"award-info":[{"award-number":["F20-02343"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["F20-02015"],"award-info":[{"award-number":["F20-02015"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2021,12,17]]},"abstract":"<jats:p>Infection and viral entry of SARS-CoV-2 crucially depends on the binding of its Spike protein to angiotensin converting enzyme 2 (ACE2) presented on host cells. Glycosylation of both proteins is critical for this interaction. Recombinant soluble human ACE2 can neutralize SARS-CoV-2 and is currently undergoing clinical tests for the treatment of COVID-19. We used 3D structural models and molecular dynamics simulations to define the ACE2 N-glycans that critically influence Spike-ACE2 complex formation. Engineering of ACE2 N-glycosylation by site-directed mutagenesis or glycosidase treatment resulted in enhanced binding affinities and improved virus neutralization without notable deleterious effects on the structural stability and catalytic activity of the protein. Importantly, simultaneous removal of all accessible N-glycans from recombinant soluble human ACE2 yields a superior SARS-CoV-2 decoy receptor with promise as effective treatment for COVID-19 patients.<\/jats:p>","DOI":"10.7554\/elife.73641","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T08:00:26Z","timestamp":1639987226000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.73641","source":"Crossref","is-referenced-by-count":44,"title":["Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor"],"prefix":"10.7554","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2547-067X","authenticated-orcid":true,"given":"T\u00fcmay","family":"Capraz","sequence":"first","affiliation":[{"name":"Institute for Molecular Modeling and Simulation, University of Natural Resources and Life Sciences (BOKU)","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8057-3930","authenticated-orcid":true,"given":"Nikolaus F","family":"Kienzl","sequence":"first","affiliation":[{"name":"Institute of Plant Biotechnology and Cell Biology, Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences (BOKU)","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5234-5524","authenticated-orcid":true,"given":"Elisabeth","family":"Laurent","sequence":"first","affiliation":[{"name":"Institute of Molecular Biotechnology, Department of Biotechnology and Core Facility Biomolecular & Cellular Analysis, University of Natural Resources and Life Sciences (BOKU)","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8575-0278","authenticated-orcid":true,"given":"Jan W","family":"Perthold","sequence":"additional","affiliation":[{"name":"Institute for Molecular Modeling and Simulation, University of Natural Resources and Life Sciences (BOKU)","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2066-1036","authenticated-orcid":true,"given":"Esther","family":"F\u00f6derl-H\u00f6benreich","sequence":"additional","affiliation":[{"name":"Diagnostic and Research Institute of Pathology, Medical University of Graz","place":["Graz, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6097-8348","authenticated-orcid":true,"given":"Clemens","family":"Gr\u00fcnwald-Gruber","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry, Department of Chemistry, University of Natural Resources and Life Sciences","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Maresch","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry, Department of Chemistry, University of Natural Resources and Life Sciences","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2652-5695","authenticated-orcid":true,"given":"Vanessa","family":"Monteil","sequence":"additional","affiliation":[{"name":"Karolinska Institute, Department of Laboratory Medicine","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Niederh\u00f6fer","sequence":"additional","affiliation":[{"name":"Apeiron Biologics","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7035-7038","authenticated-orcid":true,"given":"Gerald","family":"Wirnsberger","sequence":"additional","affiliation":[{"name":"Apeiron Biologics","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mirazimi","sequence":"additional","affiliation":[{"name":"Karolinska Institute, Department of Laboratory Medicine","place":["Stockholm, Sweden"]},{"name":"National Veterinary Institute","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5299-7218","authenticated-orcid":true,"given":"Kurt","family":"Zatloukal","sequence":"additional","affiliation":[{"name":"Diagnostic and Research Institute of Pathology, Medical University of Graz","place":["Graz, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9013-5408","authenticated-orcid":true,"given":"Lukas","family":"Mach","sequence":"additional","affiliation":[{"name":"Institute of Plant Biotechnology and Cell Biology, Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences (BOKU)","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8194-3777","authenticated-orcid":true,"given":"Josef M","family":"Penninger","sequence":"additional","affiliation":[{"name":"IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Dr. Bohr","place":["Vienna, Austria"]},{"name":"Department of Medical Genetics, Life Sciences Institute, University of British Columbia","place":["Vancouver, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4232-2556","authenticated-orcid":true,"given":"Chris","family":"Oostenbrink","sequence":"additional","affiliation":[{"name":"Institute for Molecular Modeling and Simulation, University of Natural Resources and Life Sciences (BOKU)","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5693-6690","authenticated-orcid":true,"given":"Johannes","family":"Stadlmann","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry, Department of Chemistry, University of Natural Resources and Life Sciences","place":["Vienna, Austria"]},{"name":"IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Dr. Bohr","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2020.166762","article-title":"Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition","volume":"433","author":"Allen","year":"2021","journal-title":"Journal of Molecular Biology"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nature Medicine"},{"key":"bib3","first-page":"S49","article-title":"Limit of blank, limit of detection and limit of quantitation","volume":"29","author":"Armbruster","year":"2008","journal-title":"The Clinical Biochemist. Reviews"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"Barnes","year":"2020","journal-title":"Nature"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.bpj.2020.10.036","article-title":"The flexibility of ACE2 in the context of SARS-CoV-2 infection","volume":"120","author":"Barros","year":"2021","journal-title":"Biophysical Journal"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"19944","DOI":"10.1073\/pnas.0808116105","article-title":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice","volume":"105","author":"Becker","year":"2008","journal-title":"PNAS"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41586-020-2772-0","article-title":"Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion","volume":"588","author":"Benton","year":"2020","journal-title":"Nature"},{"key":"bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/978-94-015-7658-1_21","volume-title":"Intermolecular Forces","author":"Berendsen","year":"1981"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"The Journal of Chemical Physics"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bpj.2018.11.3126","article-title":"GROmarhos: A GROMACS-Based Toolset to Analyze Density Maps Derived from Molecular Dynamics Simulations","volume":"116","author":"Briones","year":"2019","journal-title":"Biophysical Journal"},{"key":"bib11","doi-asserted-by":"publisher","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"The Journal of Chemical Physics"},{"key":"bib12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190974","article-title":"A detection and quantification label-free tool to speed up downstream processing of model mucins","volume":"13","author":"Carvalho","year":"2018","journal-title":"PLOS ONE"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1021\/acscentsci.0c01056","article-title":"Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein","volume":"6","author":"Casalino","year":"2020","journal-title":"ACS Central Science"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1126\/science.abc0870","article-title":"Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2","volume":"369","author":"Chan","year":"2020","journal-title":"Science"},{"key":"bib15","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-516695\/v1","article-title":"A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo","volume":"10","author":"Chan","year":"2021","journal-title":"Nature"},{"key":"bib16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20457-w","article-title":"Host and viral determinants for efficient SARS-CoV-2 infection of the human lung","volume":"12","author":"Chu","year":"2021","journal-title":"Nature Communications"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1021\/ct300977f","article-title":"Random Coordinate Descent with Spinor-matrices and Geometric Filters for Efficient Loop Closure","volume":"9","author":"Chys","year":"2013","journal-title":"Journal of Chemical Theory and Computation"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1021\/acs.jcim.1c00241","article-title":"Anchor-Locker Binding Mechanism of the Coronavirus Spike Protein to Human ACE2: Insights from Computational Analysis","volume":"61","author":"Cong","year":"2021","journal-title":"Journal of Chemical Information and Modeling"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/prot.26086","article-title":"Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor","volume":"89","author":"Delgado","year":"2021","journal-title":"Proteins"},{"key":"bib20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/30.2.e9","article-title":"High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells","volume":"30","author":"Durocher","year":"2002","journal-title":"Nucleic Acids Research"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1021\/ct2003622","article-title":"GROMOS++ Software for the Analysis of Biomolecular Simulation Trajectories","volume":"7","author":"Eichenberger","year":"2011","journal-title":"Journal of Chemical Theory and Computation"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"28046","DOI":"10.1073\/pnas.2016093117","article-title":"Engineered ACE2 receptor traps potently neutralize SARS-CoV-2","volume":"117","author":"Glasgow","year":"2020","journal-title":"PNAS"},{"key":"bib23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71748-7","article-title":"Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition","volume":"10","author":"Grant","year":"2020","journal-title":"Scientific Reports"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: A linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"Journal of Computational Chemistry"},{"key":"bib25","first-page":"136","article-title":"The potential calculations and some applications","volume":"9","author":"Hockney","year":"1970","journal-title":"Methods in Computational Physics"},{"key":"bib26","doi-asserted-by":"publisher","DOI":"10.1201\/9780367806934","volume-title":"Computer Simulation Using Particles","author":"Hockney","year":"1988"},{"key":"bib27","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108375","article-title":"Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites","volume":"40","author":"Hoffmann","year":"2021","journal-title":"The EMBO Journal"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/BF00124016","article-title":"Local elevation: a method for improving the searching properties of molecular dynamics simulation","volume":"8","author":"Huber","year":"1994","journal-title":"Journal of Computer-Aided Molecular Design"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/j.1476-5381.2009.00604.x","article-title":"Ligand binding assays at equilibrium: validation and interpretation","volume":"161","author":"Hulme","year":"2010","journal-title":"British Journal of Pharmacology"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41586-021-03237-4","article-title":"Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis","volume":"591","author":"Johnson","year":"2021","journal-title":"Nature"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","article-title":"The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"key":"bib33","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-042420-113838","article-title":"SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment","volume":"73","author":"Li","year":"2021","journal-title":"Annual Review of Medicine"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.str.2017.04.014","article-title":"Fcab-HER2 Interaction: a Menage a Trois","volume":"25","author":"Lobner","year":"2017","journal-title":"Lessons from X-Ray and Solution Studies. Structure"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"W395","DOI":"10.1093\/nar\/gkw395","article-title":"RCD+: Fast loop modeling server","volume":"44","author":"L\u00f3pez-Blanco","year":"2016","journal-title":"Nucleic Acids Research"},{"key":"bib36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002900","article-title":"Virus neutralisation: new insights from kinetic neutralisation curves","volume":"9","author":"Magnus","year":"2013","journal-title":"PLOS Computational Biology"},{"key":"bib37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2100425118","article-title":"Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike","volume":"118","author":"Mehdipour","year":"2021","journal-title":"PNAS"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/s0022-2836(65)80285-6","article-title":"On the nature of allosteric transitions: a plausible model","volume":"12","author":"Monod","year":"1965","journal-title":"Journal of Molecular Biology"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"bib40","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013426","article-title":"Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection","volume":"13","author":"Monteil","year":"2021","journal-title":"EMBO Molecular Medicine"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.bpj.2021.01.012","article-title":"Elucidation of interactions regulating conformational stability and dynamics of SARS-CoV-2 S-protein","volume":"120","author":"Mori","year":"2021","journal-title":"Biophysical Journal"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1080\/00268978300102851","article-title":"Constant pressure molecular dynamics for molecular systems","volume":"50","author":"Nos\u00e9","year":"2006","journal-title":"Molecular Physics"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: A new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"Journal of Applied Physics"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.carres.2010.05.026","article-title":"Conformational properties of glucose-based disaccharides investigated using molecular dynamics simulations with local elevation umbrella sampling","volume":"345","author":"Peri\u0107-Hassler","year":"2010","journal-title":"Carbohydrate Research"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1021\/ct300479h","article-title":"GROMOS 53A6GLYC, an Improved GROMOS Force Field for Hexopyranose-Based Carbohydrates","volume":"8","author":"Pol-Fachin","year":"2012","journal-title":"Journal of Chemical Theory and Computation"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/jcc.23721","article-title":"Extension and validation of the GROMOS 53A6(GLYC) parameter set for glycoproteins","volume":"35","author":"Pol-Fachin","year":"2014","journal-title":"Journal of Computational Chemistry"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5501\/wjv.v5.i2.85","article-title":"Determination of 50% endpoint titer using a simple formula","volume":"5","author":"Ramakrishnan","year":"2016","journal-title":"World Journal of Virology"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1021\/ct300156h","article-title":"New Interaction Parameters for Charged Amino Acid Side Chains in the GROMOS Force Field","volume":"8","author":"Reif","year":"2012","journal-title":"Journal of Chemical Theory and Computation"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1021\/ct300874c","article-title":"Testing of the GROMOS Force-Field Parameter Set 54A8: Structural Properties of Electrolyte Solutions, Lipid Bilayers, and Proteins","volume":"9","author":"Reif","year":"2013","journal-title":"Journal of Chemical Theory and Computation"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.cpc.2011.12.014","article-title":"Architecture, implementation and parallelisation of the GROMOS software for biomolecular simulation","volume":"183","author":"Schmid","year":"2012","journal-title":"Computer Physics Communications"},{"key":"bib51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1008790","article-title":"Computational epitope map of SARS-CoV-2 spike protein","volume":"17","author":"Sikora","year":"2021","journal-title":"PLOS Computational Biology"},{"key":"bib52","doi-asserted-by":"publisher","DOI":"10.1002\/cpmc.100","article-title":"SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup","volume":"57","author":"Stadlbauer","year":"2020","journal-title":"Current Protocols in Microbiology"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.eng.2020.07.014","article-title":"Mass Spectrometry Analysis of Newly Emerging Coronavirus HCoV-19 Spike Protein and Human ACE2 Reveals Camouflaging Glycans and Unique Post-Translational Modifications","volume":"7","author":"Sun","year":"2021","journal-title":"Engineering"},{"key":"bib54","doi-asserted-by":"publisher","DOI":"10.1038\/s41557-021-00758-3","article-title":"A glycan gate controls opening of the SARS-CoV-2 spike protein","volume":"10","author":"Sztain","year":"2021","journal-title":"Nature Chemistry"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1021\/acs.jcim.7b00351","article-title":"Modeling of Oligosaccharides within Glycoproteins from Free-Energy Landscapes","volume":"57","author":"Turupcu","year":"2017","journal-title":"Journal of Chemical Information and Modeling"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Research"},{"key":"bib61","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.61312","article-title":"Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants","volume":"9","author":"Weisblum","year":"2020","journal-title":"eLife"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/nrm4073","article-title":"Glycosylation-directed quality control of protein folding","volume":"16","author":"Xu","year":"2015","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"bib66","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.61552","article-title":"Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration","volume":"9","author":"Yang","year":"2020","journal-title":"eLife"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.abh1139","article-title":"Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants","volume":"373","author":"Yuan","year":"2021","journal-title":"Science"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.chom.2020.08.004","article-title":"Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor","volume":"28","author":"Zhao","year":"2020","journal-title":"Cell Host & Microbe"},{"key":"bib69","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"bib70","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"The New England Journal of Medicine"},{"key":"bib71","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41557-021-00707-0","article-title":"SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome","volume":"13","author":"Zimmerman","year":"2021","journal-title":"Nature Chemistry"},{"key":"bib72","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/S2213-2600(20)30418-5","article-title":"Human recombinant soluble ACE2 in severe COVID-19","volume":"8","author":"Zoufaly","year":"2020","journal-title":"The Lancet. Respiratory Medicine"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/73641\/elife-73641-v2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/73641\/elife-73641-v2.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/73641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T21:23:23Z","timestamp":1697059403000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/73641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,20]]},"references-count":72,"alternative-id":["10.7554\/eLife.73641"],"URL":"https:\/\/doi.org\/10.7554\/elife.73641","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.31.458325","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2021.08.31.458325","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"accession","id":"covid","asserted-by":"subject"}],"has-review":[{"id-type":"doi","id":"10.7554\/eLife.73641.sa2","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.73641.sa1","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.73641.sa0","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,20]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"e73641"}}